Sumitomo and Torrent reach Settlement Agreement on Patent Lawsuit over Aptiom Drug

shot by IP News Shots / 4:40 pm on 22 November, 2021

Sunovion Pharmaceuticals, Inc., a subsidiary of Sumitomo Dainippon Pharma Co., Ltd. and Bial – Portela & CA SA have affirmed settlement of patent dispute against Torrent Pharmaceuticals, Ltd. The U.S. District Court for the District of Delaware has ruled to block sales of Torrent’s generic for Aptiom drug for seizure treatment until the expiration of 10 patents “except as otherwise provided in the settlement agreement” and “unless pursuant to a license”.

Industry: Pharmaceuticals | Type of IP: Litigations

Read more at Bloomberg Law